Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2013

01-07-2013 | Original paper

Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties

Authors: Ling Wang, Terrell Zollinger, Jianjun Zhang

Published in: Cancer Causes & Control | Issue 7/2013

Login to get access

Abstract

Background

Although a growing body of evidence from experimental and clinical studies suggests that Helicobacter pylori may play a role in liver cancer etiology, few epidemiologic studies have investigated this hypothesis.

Methods

Liver cancer mortality rates in 1986–1988 for the 67 Chinese counties were obtained from a nationwide survey among subjects aged 35–69 years. Blood samples were collected from selected individuals of the similar age range in the same 67 counties in 1989. H. pylori infection was evaluated by measuring its antibodies (IgG) in plasma samples using an enzyme-linked immunosorbent assay (ELISA). Pearson correlation and multiple regression analyses were performed to test our hypothesis.

Results

Prevalence rates of H. pylori infection were positively correlated with liver cancer mortality in both men (r = 0.43, p = 0.0002) and women (r = 0.41, p = 0.0005). This significant association persisted after adjustment for body mass index, income, cigarette smoking, alcohol consumption, HBsAg positivity, diabetes mortality, and salt-preserved vegetable intake. Stratified analysis revealed suggestive interactions of H. pylori prevalence with HBsAg positivity and urinary aflatoxin M1 in men in relation to liver cancer mortality.

Conclusion

The present study offers novel epidemiologic evidence suggesting that infection with H. pylori is associated with an increased risk of death from liver cancer among rural Chinese residents.
Literature
1.
AdC Romero, Baroni Ferreira TR, dos Santos Dias CT, Calori-Domingues MA, da Gloria EM (2010) Occurrence of AFM(1) in urine samples of a Brazilian population and association with food consumption. Food Control 21:554–558CrossRef
2.
Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Megraud F (2000) Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89:1431–1439PubMedCrossRef
3.
Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA (2009) Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 1155:206–221PubMedCrossRef
4.
Boonyanugomol W, Chomvarin C, Baik SC, Song JY, Hahnvajanawong C, Kim KM, Cho MJ, Lee WK, Kang HL, Rhee KH, Sripa B (2011) Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells. Dig Dis Sci 56:1682–1692PubMedCrossRef
5.
Cellini L, Allocati N, Piattelli A, Petrelli I, Fanci P, Dainelli B (1995) Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. New Microbiol 18:187–192PubMed
6.
Chen NL, Bai L, Deng T, Zhang C, Kong QY, Chen H (2004) Expression of hepatitis B virus antigen and Helicobacter pylori infection in gastric mucosa of patients with chronic liver disease. Hepatobiliary Pancreat Dis Int 3:223–225PubMed
7.
Chen J, Peto R, Pan W, Liu B, Campbell T, Boreham J, Parpia B, Cassano P, Chen Z (2006) Mortality, biochemistry, diet and lifestyle in rural China: geographic study of the characteristics of 69 counties in Mainland China and 16 areas in Taiwan. Oxford University Press, Oxford
8.
9.
Coppola N, De Stefano G, Marrocco C, Scarano F, Scolastico C, Tarantino L, Rossi G, Battaglia M, Onofrio M, D’Aniello F, Pisapia R, Sagnelli C, Sagnelli E, Piccinino F, Giorgio A, Filippini P (2003) Helicobacter spp. and liver diseases. Infez Med 11:201–207PubMed
10.
11.
Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR (2002) Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci 47:1638–1643PubMedCrossRef
12.
Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A 98:14601–14606PubMedCrossRef
13.
El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRef
14.
Fan XG, Peng XN, Huang Y, Yakoob J, Wang ZM, Chen YP (2002) Helicobacter species ribosomal DNA recovered from the liver tissue of Chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 35:1555–1557PubMedCrossRef
15.
Ferguson DA Jr, Li C, Patel NR, Mayberry WR, Chi DS, Thomas E (1993) Isolation of Helicobacter pylori from saliva. J Clin Microbiol 31:2802–2804PubMed
16.
Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ Jr, Gorelick PL, Ward JM (1994) Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32:1238–1245PubMed
17.
Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, Hayward A, Belcher JC, Mendes EN (1995) Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 33:445–454PubMed
18.
Fox JG, Drolet R, Higgins R, Messier S, Yan L, Coleman BE, Paster BJ, Dewhirst FE (1996) Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34:2479–2482PubMed
19.
Gao S, Yang WS, Zhang W, Gao J, Xiang YB (2010) Analysis and comparison of population-based survival rates of patients with primary liver cancer worldwide. Tumor 30:1027–1034
20.
Guan Y (1993) A study on the relationship between Helicobacter pylori and chronic gastritis and peptic ulcer by the case-control method and sequential analysis. Zhonghua Liu Xing Bing Xue Za Zhi 14:75–77PubMed
21.
Huang Y, Fan XG, Zhou JH (2004) Immunohistochemistry of Helicobacter pylori in primary liver carcinoma tissues. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29:15–17PubMed
22.
Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N (2004) Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 57:1273–1277PubMedCrossRef
23.
Ito K, Nakamura M, Toda G, Negishi M, Torii A, Ohno T (2004) Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 13:221–227PubMed
24.
Ito K, Yamaoka Y, Yoffe B, Graham DY (2008) Disturbance of apoptosis and DNA synthesis by Helicobacter pylori infection of hepatocytes. Dig Dis Sci 53:2532–2540PubMedCrossRef
25.
Konturek JW (2003) Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. J Physiol Pharmacol 54(Suppl 3):23–41PubMed
26.
Liu Y, Chang CC, Marsh GM, Wu F (2012) Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer 48:2125–2136PubMedCrossRef
27.
Mahady GB, Pendland SL, Stoia A, Hamill FA, Fabricant D, Dietz BM, Chadwick LR (2005) In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 19:988–991PubMedCrossRef
28.
29.
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
30.
Pellicano R, Mazzaferro V, Grigioni WF, Cutufia MA, Fagoonee S, Silengo L, Rizzetto M, Ponzetto A (2004) Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 10:598–601PubMed
31.
Piantadosi S, Byar DP, Green SB (1988) The ecological fallacy. Am J Epidemiol 127:893–904PubMed
32.
Prieto J (2008) Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 48:380–381PubMedCrossRef
33.
Quaglia NC, Dambrosio A, Normanno G, Parisi A, Patrono R, Ranieri G, Rella A, Celano GV (2008) High occurrence of Helicobacter pylori in raw goat, sheep and cow milk inferred by glmM gene: a risk of food-borne infection? Int J Food Microbiol 124:43–47PubMedCrossRef
34.
Satoh K, Yoshida Y, Taniguchi Y, Kimura K (1993) Relationship between Helicobacter pylori colonization in the gastric mucosa and the severity of atrophic gastritis. Nihon Rinsho 51:3227–3230PubMed
35.
Studach LL, Menne S, Cairo S, Buendia MA, Hullinger RL, Lefrancois L, Merle P, Andrisani OM (2012) A subset of Suz12/PRC2 target genes is activated during HBV replication and liver carcinogenesis associated with hepatitis B virus X protein. Hepatology 56:1240–1251PubMedCrossRef
36.
Tan VP, Wong BC (2011) Helicobacter pylori and gastritis: untangling a complex relationship 27 years on. J Gastroenterol Hepatol 26(Suppl 1):42–45PubMedCrossRef
37.
Verhoef C, Pot RG, de Man RA, Zondervan PE, Kuipers EJ, JN IJ, Kusters JG (2003) Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 15:1171–1174PubMedCrossRef
38.
Vivekanandan P, Torbenson M (2008) Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States. Hum Pathol 39:213–216PubMedCrossRef
39.
Wang N, Zheng Y, Yu X, Lin W, Chen Y, Jiang Q (2009) Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer. Am J Epidemiol 169:990–995PubMedCrossRef
40.
Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV et al (1994) Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222–1227PubMedCrossRef
41.
Xuan SY, Li N, Qiang X, Zhou RR, Shi YX, Jiang WJ (2006) Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol 12:2335–2340PubMed
42.
Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12:17–20PubMed
Metadata
Title
Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties
Authors
Ling Wang
Terrell Zollinger
Jianjun Zhang
Publication date
01-07-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 7/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0211-3

Other articles of this Issue 7/2013

Cancer Causes & Control 7/2013 Go to the issue

Original paper

Is a cancer diagnosis a teachable moment for the patient’s relative who smokes?

Original paper

Anthropometric, behavioral, and female reproductive factors and risk of multiple myeloma: a pooled analysis

Original paper

Cancer incidence and mortality of Surinamese migrants in the Netherlands: in-between Surinamese and Dutch levels?

Original paper

Body mass index, body mass change, and risk of oral cavity cancer: results of a large population-based case–control study, the ICARE study

Original paper

A prospective cohort study of shift work and the risk of death from pancreatic cancer in Japanese men

Original paper

Risk of colorectal cancer associated with active smoking among female teachers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits